Activities of β-Lactams and Macrolides against Helicobacter pylori

Author:

Hassan Ibrahim J.1,Stark Roger M.1,Greenman John2,Millar Michael R.1

Affiliation:

1. Pathology and Microbiology Department, University of Bristol, Bristol BS2 8HW,1 and

2. Faculty of Applied Sciences, University of the West of England, Frenchay, Bristol BS16 1QY,2 United Kingdom

Abstract

ABSTRACT A continuous-culture system (chemostat) was used to study the activities of β-lactam antimicrobial agents, clarithromycin, and 14-OH-clarithromycin against slowly growing Helicobacter pylori NCTC 11637. H. pylori was grown to steady state before exposure to these antimicrobial agents at ×8 the MIC. The bactericidal actions of combinations of amoxicillin and clarithromycin were also studied. Viable counts (numbers of CFU per milliliter) were determined at 2-h intervals for 12 h and at 20 h after the addition of antibiotics. The effects of pH changes (6.5 to 7.4) on the activities of amoxicillin, clarithromycin, and the combination of these against H. pylori NCTC 11637 were also studied. Viable counts following exposure to ampicillin, cefixime, ceftazidime, cefuroxime, cefotaxime, azlocillin, and piperacillin at 20 h showed bacteriostatic activity. Imipenem, meropenem, amoxicillin, clarithromycin, and 14-OH-clarithromycin reduced the viable counts by 3 log 10 CFU/ml (≥99.9% killing). Imipenem was the most rapidly bactericidal against H. pylori NCTC 11637. Results of the pH experiments showed that amoxicillin was bactericidal at pHs 6.5 to 7.4. Clarithromycin was bactericidal at pH 7.0 to 7.4 but was bacteriostatic at pH 6.5. The combination of amoxicillin and clarithromycin was bactericidal at pHs 6.5 and 7.0. A batch culture (flask system) was also used to investigate 12 strains of H. pylori for their susceptibilities to β-lactams, clarithromycin, and/or 14-OH-clarithromycin in order to determine whether results from the chemostat model can be reproduced with batch cultures. Results of the chemostat time-kill kinetic study were reproducible in our batch culture flask system. The role of carbapenems in the eradication of H. pylori should be investigated.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference43 articles.

1. I/V omeprazole/amoxycillin and omeprazole pre-treatment in Helicobacter pylori positive acute peptic ulcer bleeding. A pilot study.;Adamek R. J.;Scand. J. Gastroenterol.,1994

2. Anhalt J. P. Assays of antimicrobial agents in body fluid Manual of clinical microbiology 4th ed. Lennette E. H. Balows A. Hausler W. J. Jr. Shadomy H. J. 1985 1009 1014 American Society for Microbiology Washington D.C

3. Aoki H. Sekiguchi M. Akahane K. Tsutomi Y. Korenaga H. Hayano T. Hayakawa I. A new oral carbapenem antibiotic. 3. Pharmacokinetics and safety in laboratory animals abstr. F135 Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995 136 American Society for Microbiology Washington D.C

4. In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin

5. Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease.;Borsch G.;Scand. J. Gastroenter.,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3